Previous research has shown that high expression of PIM3 is a poor prognostic factor for DLBCL patients and is associated with common mutated genes in DLBCL, such as MYD88, MYC, and BTK (Wang et al., 2023). This evidence concerns the gene MYC and diffuse large B-cell lymphoma.